The government has announced a new plan to include a two-dose chickenpox vaccine in the childhood immunization schedule for all babies born on or after October 1, 2024. The vaccine will be administered at 12 months and again when the child enters junior infants. There is no catch-up program for those born before this date, who will need to get vaccinated privately. Despite initial concerns about the duration of efficacy, authorities, including HICWA, have determined the benefits outweigh risks. A vaccination uptake of 80% is necessary to achieve herd immunity and protect vulnerable groups. Common side effects are minimal, and the vaccine aims to significantly reduce chickenpox and associated complications in the community. The podcast encourages all eligible people to get vaccinated to ensure broad protection for the population.

In this episode:

00:00  Government Announces Chickenpox Vaccine for Children

00:29  Details of the Vaccine Schedule

00:41  Evaluating the Vaccine's Efficacy and Risks

01:18  Chickenpox: A Common and Serious Disease

02:05  Global Adoption of the Chickenpox Vaccine

02:37  Importance of High Vaccination Uptake

02:53  Two-Dose Schedule and Its Benefits

03:48  Potential Risks and Concerns

05:06  Complications and Risks of Chickenpox

06:03  Special Considerations for Pregnant Women

07:44  Who Should Not Get the Vaccine?

08:41  Post-Vaccination Transmission and Side Effects

10:18  Summary and Call to Action

11:12  Conclusion and Contact Information

Season 9 Partnership

– Salin Plus (available here!)

I am so thrilled to be partnering with Salin plus  This 100% natural salt therapy device is suitable for both adults and children! Tune in to learn more!

Support this Podcast

Simply following and reviewing this podcast can make a huge difference! If you enjoy this episode I would be so grateful if you could follow or subscribe to the show!

#childrenshealth #familyhealth #healthireland #pharmacy #pharmacist #chickenpoxvaccine #chickenpox

Hosted on Acast. See acast.com/privacy for more information.